NIH PA · NIH · R21
PA-25-304: NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.
- NOFO number
- PA-25-304
- Type
- PA
- Activity code
- R21
- Primary institute
- NIH
- Clinical trials
- Not Allowed
- Posted
- Dec 18, 2024
- Opens
- Jan 16, 2025
- Expires
- Jan 8, 2028
PA-25-304 due dates
4 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 16, 2025 | March 16, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 16, 2025 | July 16, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 16, 2025 | November 16, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 16, 2026 | March 16, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 16, 2026 | July 16, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 16, 2026 | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
| February 16, 2027 | March 16, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| June 16, 2027 | July 16, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
| October 16, 2027 | November 16, 2027 * | Not Applicable | March 2028 | May 2028 | July 2028 |
Projects funded under PA-25-304
NIH RePORTER lists 1,216 projects funded under PA-25-304 in FY2022–FY2026, with $435.2M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
1,216
Distinct projects, FY2022–FY2026
New awards
1,214
Type 1 (new project) award records
NIH funding
$435.2M
Award dollars under PA-25-304, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 9 | 9 | $3.7M |
| FY2026 | 1,211 | 1,205 | $431.5M |
Institutions with the most funding
- University of Pittsburgh at Pittsburgh$11.8M · 31 projects
- Univ of North Carolina Chapel Hill$11.1M · 32 projects
- University of California, San Diego$8.6M · 22 projects
- Washington University$8.5M · 23 projects
- University of Colorado Denver$8.2M · 22 projects
- University of Michigan at Ann Arbor$8.1M · 23 projects
- Johns Hopkins University$7.9M · 24 projects
- University of Florida$7.2M · 19 projects
Funding institutes
- NIAID$182.7M · 589
- NICHD$52.6M · 122
- NIA$49.5M · 117
- NCI$21.4M · 52
- NIAMS$17.7M · 51
- NIDCR$16.7M · 39
- NEI$16.2M · 37
- NIMH$15.2M · 35
Activity codes funded
- R211,218 records
- UH22 records
Most recent new awards
- Multilayer coordination of stratified epithelial wound closure (opens NIH RePORTER)
University of Washington · 1R21AR088908-01 · NIAMS · Notice Sep 24, 2026
$165KR21
- Role of Gq signaling for PTH1R-dependent bone growth (opens NIH RePORTER)
Massachusetts General Hospital · 1R21AR088883-01 · NIAMS · Notice Sep 23, 2026
$200KR21
- Failure to resolve an adaptive stress state contributes to Duchenne Muscular Dystrophy Severity (opens NIH RePORTER)
University of Southern California · 1R21AR088867-01 · NIAMS · Notice Sep 22, 2026
$212KR21
- Nuclear Receptors In Cancer Cachexia (opens NIH RePORTER)
University of Texas Hlth Sci Ctr Houston · 1R21AR088832-01 · NIAMS · Notice Sep 22, 2026
$201KR21
- Immunostimulatory short non-coding RNAs in systemic lupus erythematosus (opens NIH RePORTER)
Thomas Jefferson University · 1R21AR088737-01 · NIAMS · Notice Sep 22, 2026
$200KR21
- Probiotic-derived SH3b domains as effector molecules (opens NIH RePORTER)
University of Florida · 1R21AT014079-01 · NCCIH · Notice Sep 22, 2026
$398KR21
What its predecessor PA-20-195 funded
PA-25-304 reissues PA-20-195. Its funding history is the best guide to who wins under this program: 4,428 projects and $1.73B in FY2022–FY2026.
Projects funded
4,428
Distinct projects, FY2022–FY2026
New awards
3,771
Type 1 (new project) award records
NIH funding
$1.73B
Award dollars under PA-20-195, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 1,564 | 906 | $348.4M |
| FY2023 | 1,943 | 1,112 | $461.3M |
| FY2024 | 1,812 | 935 | $424.4M |
| FY2025 | 1,565 | 796 | $427.3M |
| FY2026 | 343 | 22 | $71.4M |
Institutions with the most funding
- Washington University$37.5M · 98 projects
- Johns Hopkins University$33.7M · 84 projects
- Massachusetts General Hospital$32.4M · 78 projects
- Yale University$30.6M · 76 projects
- University of Washington$29.2M · 75 projects
- University of Pittsburgh at Pittsburgh$27.2M · 72 projects
- Duke University$27.1M · 66 projects
- Univ of North Carolina Chapel Hill$26.3M · 68 projects
Funding institutes
- NIAID$791.2M · 3,491
- NIA$202.2M · 694
- NICHD$159.8M · 623
- NEI$93.6M · 388
- NIAMS$82.0M · 378
- NIDA$70.9M · 311
- NIEHS$59.3M · 232
- NIAAA$58.4M · 256
Activity codes funded
- R217,212 records
- UH213 records
- UG32 records
Most recent new awards
- High-Throughput Combinatorial Platforms to Enhance and Expand CRISPR for Robust Gene Activation (opens NIH RePORTER)
Broad Institute, Inc. · 1R21HG014556-01 · NHGRI · Notice Sep 8, 2026
$421KR21
- Elucidating the Therapeutic Potential of Cannabidiol (CBD) in Alcohol Dependence: Targeting Neuroadaptations in the Basolateral Amygdala (opens NIH RePORTER)
University of California, San Diego · 1R21AA032100-01 · NIAAA · Notice Sep 2, 2026
$190KR21
- Chaperone-Mediated autophagy in aging-associated cardiovascular fibrosis (opens NIH RePORTER)
Albert Einstein College of Medicine · 1R21AG091151-01A1 · NIA · Notice Aug 31, 2026
$462KR21
- Impact of Stroke on Peripheral Nerve Signaling (opens NIH RePORTER)
Virginia Polytechnic Inst and St Univ · 1R21HD117190-01A1 · NICHD · Notice Aug 12, 2026
$454KR21
- Unveiling Adolescent BNST Development with Deep Learning: Implications for Alcohol Use and Negative Affect (opens NIH RePORTER)
University of Nebraska Medical Center · 1R21AA032098-01A1 · NIAAA · Notice Aug 6, 2026
$403KR21
- Imaging Glucocorticoid Function in Women with Childhood Trauma and AUD (opens NIH RePORTER)
Yale University · 1R21AA031964-01A1 · NIAAA · Notice Aug 6, 2026
$441KR21
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
23 NIH institutes and offices take applications under PA-25-304. Contact the program officer at the institute that fits your research before applying.
- NIH
- NEI · National Eye Institute
- NHGRI · National Human Genome Research Institute
- NIA · National Institute on Aging
- NIAAA · National Institute on Alcohol Abuse and Alcoholism
- NIAID · National Institute of Allergy and Infectious Diseases
- NIBIB · National Institute of Biomedical Imaging and Bioengineering
- NICHD · Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIDCD · National Institute on Deafness and Other Communication Disorders
- NIDCR · National Institute of Dental and Craniofacial Research
- NIDA · National Institute on Drug Abuse
- NIEHS · National Institute of Environmental Health Sciences
- NIMH · National Institute of Mental Health
- NINDS · National Institute of Neurological Disorders and Stroke
- NINR · National Institute of Nursing Research
- NLM · National Library of Medicine
- NCCIH · National Center for Complementary and Integrative Health
- NIMHD · National Institute on Minority Health and Health Disparities
- NIAMS · National Institute of Arthritis and Musculoskeletal and Skin Diseases
- NCI · National Cancer Institute
- NCATS · National Center for Advancing Translational Sciences
- ODSS
- NHLBI · National Heart, Lung, and Blood Institute
Related notices
Jul 16, 2026 · NOT-TR-26-010
Notice of NCATS Participation in Notice of Funding Opportunity NOFO) PA-25-304 NIH Exploratory/Developmental Research Project Grant Parent R21 Clinical Trial Not Allowed).
Jan 28, 2026 · NOT-OD-26-029
NIH Removing AIDS Application Due Dates from NOFOs. See Notice NOT-OD-26-029.
Apr 9, 2026 · NOT-NS-26-009
Notice of NINDS's Participation in PA-25-304: NIH Exploratory/Developmental Research Project Grant Parent R21 Clinical Trial Not Allowed).
Mar 26, 2026 · NOT-HL-26-003
Notice of NHLBI Participation in PA-25-304 NIH Exploratory/Developmental Research Project Grant Parent R21 Clinical Trial Not Allowed)".
Sep 2, 2025 · NOT-CA-25-118
Notice of National Cancer Institute’s Participation in PA-25-304, NIH Exploratory/Developmental Research Project Grant Parent R21 Clinical Trial Not Required) and in PA-25-306 Parent R21 Clinical Trial Required).
Aug 12, 2025 · NOT-AR-25-019
Notice of Participation in PA-25-304, NIH Exploratory/Developmental Research Project Grant Parent R21 Clinical Trial Not Allowed).
Jun 26, 2025 · NOT-MD-25-010
Notice of NIMHD Participation in PA-25-304, NIH Exploratory/Developmental Research Project Grant Parent R21 Clinical Trial Not Allowed).
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Notices of Special Interest (NOSIs)
NIH has attached 134 NOSIs to PA-25-304; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewResubmissionRevision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- The combined budget for direct costs for the two-year project period may not exceed 275,000. No more than 200,000 may be requested in any single year.
- Project period
- The total project period may not exceed 2 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PA-20-195.
- Companion NOFOs: PA-25-306, PA-25-307.
Other open NOFOs for R21
- PA-25-306NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)NIH · next due Oct 16, 2026
- PAR-25-068Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)NIDDK · next due Oct 16, 2026
- PAR-25-357NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)NEI · next due Oct 16, 2026
- PAR-25-346Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)NCI · next due Oct 16, 2026
- PAR-25-321Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)NCI · next due Oct 16, 2026
- PAR-25-266Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)NICHD · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.